- £4.30m
- £3.19m
REG - ValiRx PLC - Evaluation Agreement with Imperial College London
AnnouncementREG - ValiRx PLC - Board Re-structuring and update on requisition
AnnouncementREG - ValiRx PLC - Shareholder Requisition Notice
AnnouncementREG - ValiRx PLC - Proposed Appointment of Non-Executive Director
AnnouncementREG - ValiRx PLC - Proposed Appointment of Non-Executive Director
AnnouncementREG - ValiRx PLC - Further re Shareholder Requisition Notice
AnnouncementREG - ValiRx PLC - Holding(s) in Company
AnnouncementREG - ValiRx PLC - Agreement with Dundee Uni and Project Initiation
AnnouncementREG - ValiRx PLC - Shareholder Requisition Notice
AnnouncementREG - ValiRx PLC - Change of Broker
AnnouncementREG - ValiRx PLC - Directorate Change
AnnouncementREG - AIM - AIM Notice - 08/01/2024
AnnouncementREG - ValiRx PLC - Result of GM, Issue of Equity
AnnouncementREG - ValiRx PLC - Result of Retail Offer, Subscription
AnnouncementREG - ValiRx PLC - Posting of Circular, Notice of GM and Ops Review
AnnouncementREG - ValiRx PLC - Conditional Fundraise, Notice of General Meeting
AnnouncementREG - ValiRx PLC - Retail Offer
AnnouncementREG - ValiRx PLC - Agreement to License VAL401 to Ambrose Healthcare
AnnouncementREG - ValiRx PLC - Evaluation Agreement with StingRay Bio
Announcement